Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dZzwCfbwoceTjLgJGhtZ

November 15, 2012
Sign upForwardArchive
News for the PBM Industry

  Featured Story 
  • FDA criticized at hearing about compounding pharmacies
    The FDA needs new authority over drug compounders to avoid tragedies such as the fatal meningitis outbreak tied to contaminated custom-made drugs from the New England Compounding Center, FDA Commissioner Dr. Margaret Hamburg told members of a House Energy and Commerce subcommittee. However, several lawmakers sharply criticized the FDA, and committee Chairman Fred Upton, R-Mich., faulted the agency for not following up after finding problems years ago. The Hill/Healthwatch blog (11/14), The Washington Post (11/14) LinkedInFacebookTwitterEmail this Story
  Legislative & Regulatory News 
  • AMA backs ending pay-for-delay
    The American Medical Association issued a statement in support of banning deals between brand-name and generic-drug-makers to delay generics' market entry. "Pay for delay keeps quality, low-cost generic drugs out of the marketplace and unnecessarily drives up costs for patients," according to board member Patrice Harris in an AMA statement. Pharmalot.com/Pharma blog (11/14) LinkedInFacebookTwitterEmail this Story
  Drug Industry Spotlight 
  • Medication adherence lowers death risk in schizophrenia patients
    Researchers looking at data on more than 2,100 adult patients with schizophrenia found that those who were at least 90% compliant with their antipsychotic treatment regimen were 25% less likely to die than those with compliance below 10%. Among patients on high daily doses of first-generation antipsychotics, however, risk of death was 88% greater. The study appeared online in the journal Schizophrenia Bulletin. U.S. News & World Report/HealthDay News (11/14) LinkedInFacebookTwitterEmail this Story
  • Other News
  SmartQuote 
Keep your fears to yourself but share your courage with others."
--Robert Louis Stevenson,
Scottish novelist, poet and essayist


LinkedInFacebookTwitter

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
 
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 
 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information